When to Start Antiretroviral Therapy in Children Aged 2-5 Years: A Collaborative Causal Modelling Analysis of Cohort Studies from Southern Africa

PLoS Medicine

Volumn 10, Issue 11, 2013, Pages

  Schomaker, Michael ^a   Egger, Matthias ^b   Ndirangu, James ^c   Phiri, Sam ^d,e,x   Moultrie, Harry ^f,g   Technau, Karl ^h   Cox, Vivian ^i,j   Giddy, Janet ^k   Chimbetete, Cleophas ^l   Wood, Robin ^a,m,m   Gsponer, Thomas ^b   Bolton Moore, Carolyn ^n,o   Rabie, Helena ^p   Eley, Brian ^a   Muhe, Lulu ^q   Penazzato, Martina ^q,r   Essajee, Shaffiq ^s   Keiser, Olivia ^b   Davies, Mary Ann ^a   Hoffmann, Christopher ^t   Chi, Benjamin ^o   Naniche, Denise ^u   Dickinson, Diana ^v   Stinson, Kathryn ⁱ   Fatti, Geoffrey ^w   Wellington, Maureen ^l   Malisita, Kennedy ^y   Llenas, Jara ^z   Fritz, Christiane ^aa   Fox, Matthew ^ab   Maskew, Mhairi ^ab   Prozesky, Hans ^p   more..

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d KAMUZU CENTRAL HOSPITAL   (Malawi)

^e LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^f UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^g UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

ⁱ MÉDECINS SANS FRONTIÈRES   (Switzerland)

^j Khayelitsha ART Programme   (South Africa)

^k MCCORD HOSPITAL   (South Africa)

^l Newlands Clinic   (Zimbabwe)

^m Institute of Infectious Disease and Molecular Medicine   (South Africa)

ⁿ UNIVERSITY OF NORTH CAROLINA   (United States)

^o CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^p STELLENBOSCH UNIVERSITY   (South Africa)

^q WORLD HEALTH ORGANIZATION   (Switzerland)

^r MEDICAL RESEARCH COUNCIL   (United Kingdom)

^s CLINTON HEALTH ACCESS INITIATIVE   (United States)

^t AURUM INSTITUTE   (South Africa)

^u Ministérioda Saúde   (Mozambique)

^v Independence Surgery   (Botswana)

^w Kheth'Impilo Programme   (South Africa)

^x LIGHTHOUSE TRUST   (Malawi)

^y QUEEN ELIZABETH CENTRAL HOSPITAL   (Malawi)

^z SolidarMed SMART Programme   (Mozambique)

^aa Themba Lethu Clinic   (Zimbabwe)

^ab Tygerberg Academic Hospital   (South Africa)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; STAVUDINE;

ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHILD; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; SENSITIVITY ANALYSIS;

AFRICA, SOUTHERN; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD, PRESCHOOL; COHORT STUDIES; COOPERATIVE BEHAVIOR; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL;

EID: 84889044004     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001555     Document Type: Article

References (41)

1. Joint United Nations Programme on HIV/AIDS (2012) Report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS.
2. Leroy V, Dabis F, (2012) When should therapy begin for children infected with HIV? Lancet Infect Dis 12: 900-902.
3. Prendergast AJ, Penazzato M, Cotton M, Musoke P, Mulenga V, et al. (2012) Treatment of young children with HIV infection: using evidence to inform policymakers. PLoS Med 9 (7) (): e1001273 doi:10.1371/journal.pmed.1001273.
4. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, et al. (2008) Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 359: 2233-2244.
5. Penazzato M, Prendergast A, Tierney J, Cotton M, Gibb D, (2012) Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age. Cochrane Database Syst Rev 2012: CD004772.
6. Ananworanich J, Kosalaraksa P, Siangphoe U, Engchanil C, Pancharoen C, et al. (2008) A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS Res Ther 5: 24.
7. Puthanakit T, Ananworanich J, Vonthanak S, Kosalaraksa P, Hansudewechakul R, et al. (2013) Cognitive function and neurodevelopmental outcomes in HIV-infected children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study. Pediatr Infect Dis J 32: 501-508.
8. Puthanakit T, Bunupuradah T, (2010) Early versus deferred antiretroviral therapy in children in low-income and middle-income countries. Curr Opin HIV/AIDS 5: 12-17.
9. Puthanakit T, Saphonn V, Ananworanich J, Kosalaraksa P, Hansudewechakul R, et al. (2012) Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis 12: 933-941.
10. Cross Continents Collaboration for Kids (3Cs4kids) Analysis and Writing Committee (2008) Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS 22: 97-105.
11. Dunn D, (2003) HIV Paediatric Prognostic Markers Collaborative Study Group (2003) Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet 362: 1605-1611.
12. Dunn D, Woodburn P, Duong T, Peto J, Phillips A, et al. (2008) Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults. J Infect Dis 197: 398-404.
13. Daniel RM, Cousens SN, De Stavola BL, Kenward MG, Sterne JA, (2013) Methods for dealing with time-dependent confounding. Stat Med 32: 1584-1618.
14. Robins JM, Hernan MA, Brumback B, (2000) Marginal structural models and causal inference in epidemiology. Epidemiology 11: 550-560.
15. Gsponer T, Petersen M, Egger M, Phiri S, Maathuis MH, et al. (2012) The causal effect of switching to second-line ART in programmes without access to routine viral load monitoring. AIDS 26: 57-65.
16. World Health Organization (2010) Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach: 2010 revision. Geneva: World Health Organization.
17. Egger M, Ekouevi DK, Williams C, Lyamuya RE, Mukumbi H, et al. (2012) Cohort profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa. Int J Epidemiol 41: 1256-1264.
18. Fenner L, Brinkhof MWG, Keiser O, Weigel R, Cornell M, et al. (2010) Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in southern Africa. J Acquir Immune Defic Syndr 54: 524-532.
19. World Health Organization (2006) The WHO child growth standards. Geneva: World Health Organization.
20. Honaker J, King G, (2010) What to do about missing values in time-series cross-section data. Am J Pol Sci 54: 561-581.
21. Rubin DB, (1996) Multiple imputation after 18+ years. J Am Stat Assoc 91: 473-489.
22. Schmidt WP, Boisson S, Genser B, Barreto ML, Baisley K, et al. (2010) Weight-for-age z-score as a proxy marker for diarrhoea in epidemiological studies. J Epidemiol Community Health 64: 1074-1079.
23. World Health Organization (2007) WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: World Health Organization.
24. Curtis AJ, Marshall CS, Spelman T, Greig J, Elliot JH, et al. (2012) Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings. PLoS ONE 7 (12) (): e52019 doi:10.1371/journal.pone.0052019.
25. van der Wal WM, Prins M, Lumbreras B, Geskus RB, (2009) A simple G-computation algorithm to quantify the causal effect of a secondary illness on the progression of a chronic disease. Stat Med 28: 2325-2337.
26. Schomaker M, Gsponer T, Estill J, Fox M, Boulle A, (2013) Non-ignorable loss to follow-up: correcting mortality estimates based on additional outcome ascertainment. Stat Med E-pub ahead of print. doi:10.1002/sim.5912.
27. R Development Core Team (2010) R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
28. Edmonds A, Yotebieng M, Lusiama J, Matumona Y, Kitetele F, et al. (2011) The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLoS Med 8 (6) (): e1001044 doi:10.1371/journal.pmed.1001044.
29. Edmonds A, Yotebieng M, Lusiama J, Matumona Y, Kitetele F, et al. (2012) Quantification of CD4 responses to combined antiretroviral therapy over 5 years among HIV-infected children in Kinshasa, Democratic Republic of Congo. J Acquir Immune Defic Syndr 61: 90-98.
30. Siegfried N, Davies MA, Penazzato M, Muhe LM, Egger M, (2013) Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old. Cochrane Database Syst Rev E-pub ahead of print. doi:10.1002/14651858.CD010309.pub2.
31. Marston M, Becquet R, Zaba B, Moulton LH, Gray G, et al. (2011) Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol 40: 385-396.
32. Dunn DT, Gibb DM, Duong T, Babiker AG, Aboulker JP, et al. (2006) Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children. AIDS 20: 1289-1294.
33. Braitstein P, Songok J, Vreeman RC, Wools-Kaloustian KK, Koskei P, et al. (2011) "Wamepotea" (they have become lost): outcomes of HIV-positive and HIV-exposed children lost to follow-up from a large HIV treatment program in western Kenya. J Acquir Immune Defic Syndr 57: e40-e46.
34. McGuire M, Munyenyembe T, Szumilin E, Heinzelmann A, Le Paih M, et al. (2010) Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Trop Med Int Health 15 (Suppl 1) (): 55-62.
35. Lewis J, Walker AS, Castro H, De Rossi A, Gibb DM, et al. (2012) Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution. J Infect Dis 205: 548-556.
36. Leroy V, Malateste K, Rabie H, Lumbiganon P, Ayaya S, et al. (2013) Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr 62: 208-219.
37. Luque-Fernandez MA, Van Cutsem G, Goemaere E, Hilderbrand K, Schomaker M, et al. (2013) Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS ONE 8 (2) (): e56088 doi:10.1371/journal.pone.0056088.
38. Mugglin C, Wandeler G, Estill J, Egger M, Bender N, et al. (2013) Retention in care of HIV-infected children from HIV test to start of antiretroviral therapy: systematic review. PLoS ONE 8 (2) (): e56446 doi:10.1371/journal.pone.0056446.
39. Anaky MF, Duvignac J, Wemin L, Kouakoussui A, Karcher S, et al. (2010) Scaling up antiretroviral therapy for HIV-infected children in Cote d'Ivoire: determinants of survival and loss to programme. Bull World Health Organ 88: 490-499.
40. Braitstein P, Katshcke A, Shen CY, Sang E, Nyandiko W, et al. (2010) Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya. Trop Med Int Health 15: 833-841.
41. Honaker J, King G, Blackwell M, (2011) Amelia II: a program for missing data. J Stat Softw 45: 1-47.